Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.02
-0.44 (-2.67%)
At close: Feb 27, 2026, 4:00 PM EST
16.03
+0.01 (0.06%)
After-hours: Feb 27, 2026, 7:42 PM EST

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
--159.49-225.25-200.19-207.28
Upgrade
Depreciation & Amortization
-19.2622.2320.9213.95
Upgrade
Asset Writedown & Restructuring Costs
-7.2125.43--
Upgrade
Loss (Gain) From Sale of Investments
--8.21-9.180.747.23
Upgrade
Stock-Based Compensation
-53.6162.9155.4843.25
Upgrade
Other Operating Activities
-9.8713.7310.656.93
Upgrade
Change in Accounts Receivable
--3.742.03-22.65-7.36
Upgrade
Change in Inventory
-5.37-2.840.82-5.2
Upgrade
Change in Accounts Payable
-0.67-5.417.113.94
Upgrade
Change in Unearned Revenue
--10.48-29.29-56.5-57.73
Upgrade
Change in Other Net Operating Assets
--9.28-10.68-0.339.53
Upgrade
Operating Cash Flow
--95.21-156.32-183.95-192.73
Upgrade
Capital Expenditures
--3.66-10.7-16.35-61.75
Upgrade
Investment in Securities
-81.46140.3419.25242.96
Upgrade
Investing Cash Flow
-77.79129.652.91181.21
Upgrade
Issuance of Common Stock
-0.242.257.8926.72
Upgrade
Other Financing Activities
---124.380.43
Upgrade
Financing Cash Flow
-0.242.25132.2727.15
Upgrade
Net Cash Flow
--17.18-24.43-48.7815.63
Upgrade
Free Cash Flow
--98.88-167.02-200.29-254.47
Upgrade
Free Cash Flow Margin
--55.25%-98.09%-108.09%-164.87%
Upgrade
Free Cash Flow Per Share
--0.67-1.16-1.41-1.81
Upgrade
Cash Interest Paid
-8.868.990.49-
Upgrade
Levered Free Cash Flow
--24.48-81.95-90.17-139.1
Upgrade
Unlevered Free Cash Flow
--17.24-73.33-87.53-139.1
Upgrade
Change in Working Capital
--17.45-46.18-71.55-56.82
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.